Patent ID: 7312306

Claim:
A method of inhibiting platelet aggregation in a subject in need thereof comprising the steps of: a) selecting a thrombin receptor antagonist compound of Formula II: wherein: Y A 1 A 2 X 5-(o-Cl-cinnamamido)triazol-3-yl Cha Arg CO 5-(Thien-2-ylacrylamido)triazol-3-yl Cha Arg CO 5-(Cinnamamido)triazol-3-yl Cha Arg CO 5-(α-Me-cinnamamido)triazol-3-yl Cha Arg CO 5-(α-Ph-cinnamamido)triazol-3-yl Cha Arg CO 6-Cinnamamidopyridin-3-yl Cha Arg CO 5-Cl, 3-Me-benzothiophen-2-yl Cha Arg SO 2 5-(p-F-cinnamamido)triazol-3-yl Cha Arg CO Benzothiophen-2-yl Cha Arg CO 1-naphthyl Cha Arg SO 2 2-naphthyl Cha Arg SO 2 or any pharmaceutically acceptable salt thereof; and b) administering said compound to the subject.